DRUG NEWS

$3.95
Nursing2015
June 2012 
Volume 42  Number 6
Pages 10 - 10
 
  PDF Version Available!

ABSTRACT
Brodalumab (AMG 827), a human anti-interleukin-17-receptor monoclonal antibody, was recently tested for safety and efficacy for treating moderate-to-severe plaque psoriasis. Patients with a score of 12 or higher on the psoriasis area and severity index (PASI) and with 10% or more of their body surface area affected by psoriasis were randomly assigned to receive either brodalumab or a placebo. The primary end point of this study was to improve baseline PASI percentages.At week 12, the mean percentage improvements in the PASI score were 45% among patients receiving 70 mg of brodalumab, 85.9% for those receiving 140 mg, and 86.3% for those receiving 210 mg. The placebo group had a 16% mean improvement score. Researchers concluded that brodalumab significantly improved plaque psoriasis during this 12-week phase II trial study, conducted to determine common, short-term adverse reactions and risks in patients with plaque psoriasis.Source: Papp KA, Leonardi C, Menter A, et al. Brodalumab, an

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!


Cost:$3.95
1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Password


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.


Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.






jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Blunt Chest Trauma
Journal of Trauma Nursing, November/December 2014
Expires: 12/31/2016 CE:2 $21.95


The School Age Child with Congenital Heart Disease
MCN, The American Journal of Maternal/Child Nursing, January/February 2015
Expires: 2/28/2017 CE:2.5 $24.95


Understanding multiple myeloma
Nursing Made Incredibly Easy!, January/February 2015
Expires: 2/28/2017 CE:2 $21.95


More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles

Comprehensive Care: Looking Beyond the Presenting Problem
Journal of Christian Nursing, January/March 2015
Free access will expire on March 2, 2015.


Pain and Alzheimer dementia: A largely unrecognized problem
Nursing Made Incredibly Easy!, January/February 2015
Free access will expire on February 16, 2015.


Glycemic control in hospitalized patients
Nursing2015 Critical Care, January 2015
Free access will expire on February 16, 2015.


More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events